These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 2703382

  • 1. Importance of tumor affinity of nitroazoles in hypoxic radiosensitization.
    Kagiya T, Nishimoto S, Shibamoto Y, Wang J, Zhou L, He YL, Sasai K, Takahashi M, Abe M.
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1033-7. PubMed ID: 2703382
    [Abstract] [Full Text] [Related]

  • 2. Fluorine modification of nitroazole radiosensitizers for the enhancement of sensitizing activity with lowering toxicity: a pharmacokinetic characterization.
    Kagiya VT, Nishimoto S, Ito T, Wang J, Abe M, Sasai K.
    Int J Radiat Oncol Biol Phys; 1992 Apr; 22(3):601-5. PubMed ID: 1735699
    [Abstract] [Full Text] [Related]

  • 3. [Mechanism of action and molecular design of hypoxic cell sensitizer].
    Nishimoto S, Kagiya T.
    Gan No Rinsho; 1988 Oct; 34(13):1853-8. PubMed ID: 3199518
    [Abstract] [Full Text] [Related]

  • 4. Radiosensitization in vitro and in vivo by 3-nitrotriazoles.
    Shibamoto Y, Sakano K, Kimura R, Nishidai T, Nishimoto S, Ono K, Kagiya T, Abe M.
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1063-6. PubMed ID: 3744928
    [Abstract] [Full Text] [Related]

  • 5. Modeling of the anticancer action for radical derivatives of nitroazoles: quantitative structure-activity relationship (QSAR) study.
    Khlebnikov A, Schepetkin I, Kwon BS.
    Cancer Biother Radiopharm; 2002 Apr; 17(2):193-203. PubMed ID: 12030113
    [Abstract] [Full Text] [Related]

  • 6. Radiosensitization by a new potent nucleoside analog: 1-(1',3',4'-trihydroxy-2'-butoxy)methyl-2-nitroimidazole(RP-343).
    Murayama C, Suzuki A, Sato C, Tanabe Y, Shoji T, Miyata Y, Nishio A, Suzuki T, Sakaguchi M, Mori T.
    Int J Radiat Oncol Biol Phys; 1993 Jun 15; 26(3):433-43. PubMed ID: 8514541
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of nitroimidazole hypoxic cell radiosensitizers in a human tumor cell line high in intracellular glutathione.
    DeGraff WG, Russo A, Gamson J, Mitchell JB.
    Int J Radiat Oncol Biol Phys; 1989 Apr 15; 16(4):1021-4. PubMed ID: 2522917
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.
    Masunaga S, Uto Y, Nagasawa H, Hori H, Nagata K, Suzuki M, Kinashi Y, Ono K.
    Anticancer Res; 2006 Apr 15; 26(2A):1261-70. PubMed ID: 16619533
    [Abstract] [Full Text] [Related]

  • 9. Characteristics of fluorinated nitroazoles as hypoxic cell radiosensitizers.
    Shibamoto Y, Nishimoto S, Shimokawa K, Hisanaga Y, Zhou L, Wang J, Sasai K, Takahashi M, Abe M, Kagiya T.
    Int J Radiat Oncol Biol Phys; 1989 Apr 15; 16(4):1045-8. PubMed ID: 2703384
    [Abstract] [Full Text] [Related]

  • 10. [Recent advances in hypoxic cell radiosensitizer].
    Ono K, Takahashi M, Nishidai T, Shibamoto Y, Abe M.
    Gan No Rinsho; 1983 Oct 15; 29(13):1608-12. PubMed ID: 6230470
    [Abstract] [Full Text] [Related]

  • 11. Radiosensitization by 2-nitroimidazole nucleoside analog RP-170: radiosensitizing effects under both intravenous and oral administration.
    Murayama C, Suzuki A, Sato C, Tanabe Y, Miyata Y, Shoji T, Suzuki T, Sakaguchi M, Mori T.
    Int J Radiat Oncol Biol Phys; 1992 Oct 15; 22(3):557-60. PubMed ID: 1531214
    [Abstract] [Full Text] [Related]

  • 12. Radiosensitization by a new nucleoside analogue: 1-[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl-2-nitroimidazole (RP-170).
    Murayama C, Suzuki A, Suzuki T, Miyata Y, Sakaguchi M, Tanabe Y, Tanaka N, Mori T.
    Int J Radiat Oncol Biol Phys; 1989 Sep 15; 17(3):575-81. PubMed ID: 2528527
    [Abstract] [Full Text] [Related]

  • 13. Dual-function radiation sensitizers and bioreductive drugs: factors affecting cellular uptake and sensitizing efficiency in analogues of RSU 1069.
    Walling J, Stratford IJ, Adams GE, Stephens MA.
    Int J Radiat Biol Relat Stud Phys Chem Med; 1988 Apr 15; 53(4):641-9. PubMed ID: 3258298
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics and metabolism of the mixed-function hypoxic cell sensitizer prototype RSU 1069 in mice.
    Walton MI, Workman P.
    Cancer Chemother Pharmacol; 1988 Apr 15; 22(4):275-81. PubMed ID: 3168141
    [Abstract] [Full Text] [Related]

  • 15. [Developments in the experimental methods of evaluating hypoxic cell sensitizers].
    Shibamoto Y, Sasai K, Takahashi M, Abe M.
    Gan No Rinsho; 1988 Oct 15; 34(13):1859-63. PubMed ID: 3199519
    [Abstract] [Full Text] [Related]

  • 16. Metabolic rate modification of nitrotriazole radiosensitizers by sulfur substitution of side chain.
    Kagiya VT, Sugita T, Nishimoto S, Masuoka M, Zhou L, Abe M, Shibamoto Y, Sasai K.
    Int J Radiat Oncol Biol Phys; 1992 Oct 15; 22(3):597-600. PubMed ID: 1735698
    [Abstract] [Full Text] [Related]

  • 17. Radiosensitization, pharmacokinetics, and toxicity of a 2-nitroimidazole nucleoside (RA-263).
    Agrawal KC, Rupp WD, Rockwell S.
    Radiat Res; 1986 Feb 15; 105(2):227-39. PubMed ID: 3754053
    [Abstract] [Full Text] [Related]

  • 18. [Present status of radiation sensitizers--hypoxic cell radiosensitizer].
    Murayama C, Mori T.
    Gan To Kagaku Ryoho; 1989 Jun 15; 16(6):2135-41. PubMed ID: 2660744
    [Abstract] [Full Text] [Related]

  • 19. Studies of the in vivo and in vitro cytotoxicity of the drug RSU-1069.
    Hill RP, Gulyas S, Whitmore GF.
    Br J Cancer; 1986 Jun 15; 53(6):743-51. PubMed ID: 3755053
    [Abstract] [Full Text] [Related]

  • 20. Clinical trials of radiosensitizers: what should we expect?
    Brown JM.
    Int J Radiat Oncol Biol Phys; 1984 Mar 15; 10(3):425-9. PubMed ID: 6231272
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.